Sign in

CIK 0001077183

  • Large accelerated filer

NEOGENOMICS INC

Sign in to watch
Ticker
NEO
Exchange
Nasdaq
Industry
Services-Testing Laboratories
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
742897368
Phone
+1 239-768-0600
Business address
9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
Former names
AMERICAN COMMUNICATIONS ENTERPRISES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-10 HANNAH ALISON L. Director Grant or award +15,556 107,433
2022-06-10 HANNAH ALISON L. Director Grant or award · Stock Option (Right to Buy) +13,882 13,882
2022-06-10 Stahler Rachel A Director Grant or award +15,556 21,335
2022-06-10 Stahler Rachel A Director Grant or award · Stock Option (Right to Buy) +13,882 13,882
2022-06-10 Daly David Director Grant or award +15,556 17,179
2022-06-10 Daly David Director Grant or award · Stock Option (Right to Buy) +13,882 13,882
2022-06-10 TETRAULT LYNN A. Director Grant or award +15,556 54,667
2022-06-10 TETRAULT LYNN A. Director Grant or award · Stock Option (Right to Buy) +13,882 13,882
2022-06-01 Sikri Vishal President and CCO, Inivata Grant or award +148,455 148,455
2022-06-01 Sikri Vishal President and CCO, Inivata Grant or award · Stock Option (Right to Buy) +319,112 319,112
2022-05-18 TETRAULT LYNN A. Director Option exercise +3,334 $7.27 $24K 39,111
2022-05-18 TETRAULT LYNN A. Director Option exercise · Stock Option (Right to Buy) −3,334 0
2022-04-28 Bonello William Chief Financial Officer Option exercise +5,727 $7.52 $43K 191,548
2022-04-28 Bonello William Chief Financial Officer Option exercise · Stock Option (Right to Buy) −5,727 0
2022-04-01 Bonello William Chief Financial Officer Grant or award +82,305 185,821
2022-04-01 Sholehvar David President, Clinical Services Grant or award +30,864 30,864
2022-04-01 Sholehvar David President, Clinical Services Grant or award · Stock Option (Right to Buy) +66,372 66,372
2022-04-01 Brown Douglas Matthew Chief Strategy Officer Grant or award +82,305 158,684
2022-03-08 Bonello William Chief Financial Officer Option exercise +5,000 $7.52 $38K 103,516
2022-03-08 Bonello William Chief Financial Officer Option exercise · Stock Option (Right to Buy) −5,000 5,727

Page 20 of 23 · 447 trades